BioCT welcomes Megan Rosengarten to Board

BioCT is pleased to welcome Megan Rosengarten to the BioCT Board of Directors. Megan is a proven leader known for commercializing new insights and opportunities, resulting in sustainable growth and iconic brands. She rejoined Medtronic in January 2018 as the Vice President and General Manager for Surgical Innovations’ Surgical Robotics business. [biography]

Anthony Sabatelli and Larry Weiss have stepped down from the Board. Anthony remains on BioCT’s Government Affairs Committee. BioCT thanks Anthony and Larry for their service and the valuable contributions they have made during their tenure as directors.